Innovation in CHC 2022: NPD & Launch Activity Under the Spotlight

Thousands of innovations are launched every year in the global consumer healthcare market, but relatively few offer notable new benefits for consumers in terms of delivery format or formulation. Which new products are breaking through and offering a unique proposition? Where will new product development take the CHC market in future?

The latest title from “CHC New Products Tracker” takes an in-depth look at 100 key CHC innovations in 2021, and picks out some of the most prominent delivery format and ingredient trends in the consumer healthcare industry. It examines new product activity by region, country and leading marketer, and explores what the future might hold in terms of CHC innovation.

SAMPLE VIEWS

Global Overview

Assessing the global picture in terms of consumer healthcare innovation in 2021, including the key trends that defined the year in NPD.

Innovation Showcase - 100 key innovations in 2021

Showcasing the best CHC innovation of the past year, including:

Delivery Format Trends

Highlighting 10 major delivery format trends in the CHC market, including:

Ingredient Trends

Highlighting 10 major ingredient and labelling trends in the CHC market, including:

Innovation by Marketer

• Reviewing innovation by the leading global CHC marketers and some of the smaller companies driving new product activity in the industry

Innovation by Region & Country

• Analysing innovation trends by region (North America, Latin America, Europe and Asia-Pacific) and taking a closer look at each of the 20 countries tracked by CHC New Products Tracker

Best-in-class case studies

• Case studies of top-performing innovations from previous years

Summary & Future Trends

Setting out what the future might hold for consumer healthcare innovation and where to look for new opportunities.

• How has Covid-19 shaped new product activity in 2021 and which changes brought about by the pandemic will be long-lasting?

• What explains the apparent drop-off in terms of the volume of NPD activity and the percentage of high-quality innovation in 2021?

• Is the CHC market set for greater use of self-diagnostics and personalised medicine and probiotics?